Moravian Rhapsody
“Please, can you tell me more about the web page and mechanism behind? Is there any “scheme” of scanning published papers?” asks Professor Vojtech Adam. Yes, it’s Elisabeth Bik.
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
“Please, can you tell me more about the web page and mechanism behind? Is there any “scheme” of scanning published papers?” asks Professor Vojtech Adam. Yes, it’s Elisabeth Bik.
Dead men don’t talk. A dead colleague, especially a foreigner, is a perfect scapegoat to blame for fake data in your papers. And in your own PhD thesis.
“A complex fraud involving a Greek scientist and her network of international researchers has been uncovered by investigators from the European Anti-Fraud Office (OLAF).”
Mauro Ferrari was made to resign as ERC president. In his 3 months in office, he published a ridiculously fraudulent paper with Houston colleagues. Now Ferrari announces from his Texas lockdown “trenches” to cure COVID-19.
Anne Dejean is a very important cancer researcher in France. To whom shall she bequeath her high-achieving Institut Pasteur lab when she retires? The German shooting star Oliver Bischof is the right man to continue Dejean’s craft.
St Carlos of Oviedo almost was canonised as Spain’s first living martyr, but now Nature revoked his mentoring award. Spanish media and science elites are desperate, even the Queen is not amused. The Royal Academy of Sciences insists Lopez-Otin is a victim of journal’s failure.
The new ERC President Mauro Ferrari used to closely collaborate with two very controversial cancer researchers at MD Anderson in Texas: Anil Sood and Gabriel Lopez-Beerestein. Will that experience affect ERC’s already wanting stance on research integrity?
Two and a half years after Maria Fousteri was found guilty of scientific misconduct by her former employer, the Leiden University Medical Center (LUMC), exactly nothing at all happened. ERC and Molecular Cell ignored LUMC letters from June 2016, while Fouster’s British co-authors interfered to save own papers. Of 4 scheduled retractions, none took place.
Following my reporting, the cancer researcher Carlos López-Otín abandoned his ERC-funded 36-member-strong “Degradome” lab at the University of Oviedo in Spain and moved in with his collaborator in Paris, France, Guido Kroemer. Yet Lopez-Otin’s data integrity issues seem as poppycock compared to what Kroemer and his life partner Laurence Zitvogel dished out to the scientific community.
Janine Erler is a star of Danish cancer research, funded by ERC. Her earlier research led to the discovery of the key role of the enzyme lysyl oxidase in cancer metastasis and brought the scientist and businesswoman very close to curing cancer. Until some sad envious bad-wishers found duplicated gel bands in Erler papers.